Genpact Limited (G) Fair Value & Analysis
Technology · US · Market cap $5.6B
Genpact Limited
G · US
Fair value as of: Jun 25, 2026
From 26 valuation models · updated 4 days ago
Fair value updated Jun 25, 2026 — revised from $67.68 to $60.20 (−11.1%) since Jun 24, 2026. Share price −15.5% over the past month.
Price vs Fair Value (12 months)
12‑month range $28.35 – $49.44 · fair‑value band $43.81 – $76.59 · the $28.53 price screens below the $60.20 fair value. As of Jun 25, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Genpact Limited (G) currently trades at $28.53, while our model-based Fair Value estimate is $60.20 — implying the stock looks roughly 111.0% undervalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Genpact Limited generated revenue of $5.2B at a net margin of 11.0%. Revenue grew 6.7% year over year. It earns a return on equity of 23.1%. Net debt stands at $911M. Fundamentals as of Jun 25, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 25, 2026. TTM = trailing twelve months.
About the company
Genpact Limited provides business process outsourcing and information technology services in India, the rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers customer onboarding, customer service, collections, retail and commercial loan operations, payment operations, mortgage origination and servicing, compliance, wealth management, capital market operations support, financial crime and risk management, proprietary insurance policy suite, underwriting support, new business processing, policy administration, customer, claims management, catastrophe and exposure/risk modeling, actuarial services, end-to-end third-party administration for property and casualty claims, and technology services. The Consumer and Healthcare segment provides demand generation, sensing and planning, supply chain planning and management, pricing and trade promot…
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Genpact Limited reported revenue of $5.1B in FY2025 versus $4.0B in FY2021, a compound +6.0%/yr. Reported net income was $552M in FY2025, compounding +10.6%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Information Technology Services stocks, each showing price versus our Fair Value estimate (as of Jun 25, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| International Business Machines Corporation IBM | $252.22 | $147.06 | -42% |
| Accenture plc ACN | $124.83 | $250.14 | +100% |
| Tata Consultancy Services Limited TCS | ₹2,199 | ₹1,863 | -15% |
| Infosys Limited INFY | ₹1,198 | ₹1,237 | +3% |
| Fujitsu Limited FJTSF | $18.78 | $24.50 | +30% |
| HCL Technologies Limited HCLTECH | ₹1,132 | ₹1,230 | +9% |
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is Genpact Limited (G) undervalued?
What is the fair value of G?
What is the quality score of G?
What is the revenue of Genpact Limited (G)?
What is the net profit margin of G?
Does Genpact Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.